News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Abdul-Ahad Wajdi
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2022 |
4
| Abdul-Ahad Wajdi (Vice President, R & D, CSO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.5136, valued at
$41.1k
|
|
| 06/08/2020 |
4
| Abdul-Ahad Wajdi (Vice President, R & D, CSO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $5.13, valued at
$2.6M
|
|
| 05/27/2020 |
4
| Abdul-Ahad Wajdi (VP, R&D, CSO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 7,971 options to buy
@ $2.0663, valued at
$16.5k
Acquired 8,857 options to buy
@ $2.5405, valued at
$22.5k
|
|
| 05/27/2020 |
3
| Abdul-Ahad Wajdi (VP, R&D, CSO) has filed a Form 3 on Qualigen Therapeutics, Inc. |
|
|